Tommaso Celli

Tommaso Celli

Auto-generated profile, based on publicly available information

Tommaso Celli

Internal Medicine, Santa, Maria Nuova Hospital, Florence, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2024 in Cambridge Open Engage
Verified
Preprint
Open access
PDF file
MMMarco Marseglia
Marco Marseglia
Francesco CantiniFrancesco Cantini
Francesco Cantini
TCTommaso Celli
Tommaso Celli
EBEdoardo Brunelli
Edoardo Brunelli
GLGiuseppe Lotti
Giuseppe Lotti
The urgencies of the contemporary scenario impose on the world of design the need for complex responses; the dialogue with other disciplines becomes a fundamental planning source. In this sense, the necessity is to have an increasing need of designers capable of understanding and interacting with the hard sciences in a more conscious and complete way, in order to develop future application scenarios in every aspect of design, from materials to everyday products, up to new systemic scenarios. The contribution presents a 3CFU training experience carried out by the Design for Sustainability Laboratory (University of Florence) which had the aim of introducing students to Material Design and Biodesign. The applied methodology started from the concepts of Material Experience and Material Driven Design, including interdisciplinary skills in the design process from the early design stages. In particular, the students were led to experiment with "biotinkering" solutions with the mycelium - Pleurotus ostreatus - within a biosafety Level (BSL) 1 Lab, creating materials prototypes. In the training activities, students were provided with theoretical notions and resources relating to biology and the scientific method with the aim of combining Design and Life Sciences. From a methodological point of view, this knowledge served to provide future biodesigners with greater awareness of biotechnological processes and laboratory work. The originality and success of the Workshop consist in opening up new design horizons to future biodesigners thanks to a deep knowledge of natural processes and the possibility of consciously designing starting from the micro scale.

17 June 2023 in Internal and Emergency Medicine
Verified
Journal Article
Open access
PDF file
VVVieri Vannucchi
Vieri Vannucchi
LPLorenzo Pelagatti
Lorenzo Pelagatti
FBFabio Barone
Fabio Barone
LBLaura Bertini
Laura Bertini
TCTommaso Celli
Tommaso Celli
GLGiancarlo Landini
Giancarlo Landini
This study aimed to evaluate the effectiveness of various scoring systems in predicting in-hospital mortality for COVID-19 patients admitted to the internal medicine ward. We conducted a prospective collection of clinical data from patients admitted to the Internal Medicine Unit at Santa Maria Nuova Hospital in Florence, Italy, with confirmed pneumonia caused by SARS-CoV-2. We calculated three scoring systems: the CALL score, the PREDI-CO score, and the COVID-19 in-hospital Mortality Risk Score (COVID-19 MRS). The primary endpoint was in-hospital mortality. : A total of 681 patients were enrolled in the study, with a mean age of 68.8 ± 16.1 years, and 54.8% of them were male. Non-survivors had significantly higher scores in all prognostic systems compared to survivors (MRS: 13 [12- 15] vs. 10 [8-12]; CALL: 12 [10-12] vs. 9 [7-11]; PREDI-CO: 4 [3-6] vs. 2 [1-4]; all p<0.001). The receiver operating characteristic (ROC) analysis yielded the following area under the curve (AUC) values: MRS 0.85, CALL 0.78, PREDI-CO 0.77. The addition of Delirium and IL6 to the scoring systems improved their discriminative ability, resulting in AUC values of 0.92 for MRS, 0.87 for CALL, and 0.84 for PREDI-CO. The mortality rate increased significantly across increasing quartiles (p<0.001). In conclusion the COVID-19 in-hospital Mortality Risk Score (MRS) demonstrated reasonable prognostic stratification for patients admitted to the internal medicine ward with SARS-CoV-2-induced pneumonia. The inclusion of Delirium and IL6 as additional prognostic indicators in the scoring systems enhanced their predictive performance, specifically in determining in-hospital mortality among COVID-19 patients.